Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu | (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats:
- Alabama Drug Discovery Alliance
- Biochemistry and Molecular Genetics
- Biomatrix Engineering and Regenerative Medicine
- Cell biology
- Center for Biophysical Sciences and Engineering
- CCTS
- Center for Metabolic Bone Disease
- Microbiology
- Neurobiology
- Comprehensive Neuroscience Center
- Pathology, research shared with MS2
- Pharmacology and Toxicology
- Physiology and Biophysics
- UAB Research Foundation/IIE
- Research Administration
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
A quality-control checkpoint in pre-B cells restricts the range of antibodies produced by mature B cells, and manipulation of the checkpoint could make vaccines more potent.
The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.
The ecRNAs appear to act in memory formation, and may offer a new therapeutic approach to neuropsychiatric diseases.
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
A survival advantage for female humans stands out in a UAB review of sex differences in longevity across many species. Understanding why could inform treatments to extend healthy lifespans.
A robotic 3-D printer will build the tissue through computer-assisted design and computer-assisted manufacturing, but using living cells as the pieces of the structure.
This competitive award recognizes outstanding achievements and contributions to VA research and provides five years of salary support.
The UAB course was part of a master’s degree program in bioinformatics for researchers in Mali, where malaria is a scourge.
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.